Cancer development often entails an excess of host immune tolerance generated by regulatory T-cells, also known as "Tregs" (typically CD4 + FoxP3 + T-cells), over effector CD8 + and CD4 + Foxp3- anti-tumor T-cells in the tumor microenvironment [1]. This evidence concerns the gene CD8A and neoplasm.